REGENEREX PHARMA, INC.

CIK 1357878fmd_1NHAZCFZ4B5RNG8GZRS3F8EM11Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Dec 01, 2008 to Dec 31, 2025, 59 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.